Badreddin Edris
Founder en EDGEWISE THERAPEUTICS, INC. .
Fortuna: 10 M $ al 31/03/2024
Perfil
Badreddin Edris was the founder of Silverback Therapeutics, Inc. (founded in 2016) where he held the title of Chief Business Officer from 2016 to 2018.
He is also the founder of Edgewise Therapeutics, Inc. (founded in 2017) where he currently serves as an Independent Non-Executive Director.
In addition to his founding positions, Dr. Edris is currently the Chief Operating Officer at Springworks Therapeutics, Inc. since 2018.
Previously, Dr. Edris held the position of Principal at Genentech Ventures, Inc. and Mission Bay Capital Management, Inc. He also worked as a Principal at OrbiMed Advisors LLC from 2014 to 2018.
Dr. Edris completed his education at Stanford University, earning a graduate degree in 2009.
He also obtained an undergraduate degree from Weber State University in 2007 and a doctorate degree from Stanford University School of Medicine in 2012.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 25/03/2024 | 195 629 ( 0.27% ) | 10 M $ | 31/03/2024 | |
| 12/06/2023 | 19 820 ( 0.02% ) | 361 517 $ | 31/03/2024 |
Cargos activos de Badreddin Edris
| Empresas | Cargo | Inicio |
|---|---|---|
| SPRINGWORKS THERAPEUTICS, INC. | Chief Operating Officer | 01/01/2021 |
| EDGEWISE THERAPEUTICS, INC. | Founder | 01/01/2017 |
Antiguos cargos conocidos de Badreddin Edris.
| Empresas | Cargo | Fin |
|---|---|---|
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Corporate Officer/Principal | 01/11/2018 |
| ARS PHARMACEUTICALS, INC. | Founder | 01/09/2018 |
Mission Bay Capital Management, Inc.
 Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California. | Corporate Officer/Principal | - |
Genentech Ventures, Inc.
 Genentech Ventures, Inc. Investment ManagersFinance Genentech Ventures (Genentech Ventures) is a venture capital firm founded in 1900. The firm is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Formación de Badreddin Edris.
| Stanford University | Graduate Degree |
| Weber State University | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| EDGEWISE THERAPEUTICS, INC. | Health Technology |
| SPRINGWORKS THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
OrbiMed Advisors LLC
OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Finance |
Genentech Ventures, Inc.
Genentech Ventures, Inc. Investment ManagersFinance Genentech Ventures (Genentech Ventures) is a venture capital firm founded in 1900. The firm is headquartered in South San Francisco, CA. | Finance |
Mission Bay Capital Management, Inc.
Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California. | Finance |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson January 4, 2016 and is headquartered in Seattle, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Badreddin Edris
